Tacalyx: Funding, Investors & Team (Sep 2026)
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is dedicated to researching Tumor-Associated Carbohydrate Antigens (TACAs) as a potential new target for cancer therapy. TACAs are expressed specifically in tumors due to abnormal glycosylation, and contribute to processes like metastasis, angiogenesis, and immune suppression. Tacalyx utilizes advanced carbohydrate synthesis technology to create pure TACA structures, which are then used to develop antibodies for innovative cancer treatments.
Tacalyx has raised $7.5M across 2 funding rounds on record, the most recent a Seed announced in Apr 2026.
Tacalyx Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Tacalyx Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Tacalyx raised $7.5M in a Seed announced in Jun 2024.
1.8 years later, a Seed was announced in Apr 2026 with no disclosed amount.
Tacalyx Founders and Leadership Team
Contact details for the Tacalyx team: 1 of 2 have an email address on file.
Start 14-day free trial →Tacalyx Funding Compared to Other Biotechnology Startups
Funded Startups Like Tacalyx in Biotechnology and Berlin
Companies Similar to Tacalyx
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly…
Tacalyx Funding FAQs
What does Tacalyx do?
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is dedicated to researching Tumor-Associated Carbohydrate Antigens (TACAs) as a potential new target for cancer therapy. TACAs are expressed specifically in tumors due to abnormal glycosylation, and contribute to processes like metastasis, angiogenesis, and immune suppression. Tacalyx utilizes advanced carbohydrate synthesis technology to create pure TACA structures, which are then used to develop antibodies for innovative cancer treatments.
How much funding has Tacalyx raised?
Tacalyx has raised $7.5M across 2 rounds on record.
When did Tacalyx last raise funding?
Tacalyx's most recent funding round on record was announced in Apr 2026. The amount was not disclosed.
Who founded Tacalyx?
FundedIQ lists Jean Engela (Founder), Peter Sondermann (Founder) at Tacalyx.
Where is Tacalyx headquartered?
Tacalyx is based in Berlin, Germany.
How many employees does Tacalyx have?
Tacalyx is in the 1-10 employee band.
About FundedIQ's Tacalyx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tacalyx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.